Related references
Note: Only part of the references are listed.Bilirubin-Induced Neurologic Damage - Mechanisms and Management Approaches
Jon F. Watchko et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Exposure and Kinetics of Polycyclic Aromatic Hydrocarbons (PAHs) in Cigarette Smokers
Gideon St Helen et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2012)
Serum Bilirubin and Risk of Respiratory Disease and Death
Laura J. Horsfall et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial
Gary Parkes et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Cigarette smoking and irinotecan treatment: Pharmacokinetic interaction and effects on neutropenia
Jessica M. van der Bol et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation
SS O'Malley et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Inverse relationship between serum bilirubin and atherosclerosis in men:: A meta-analysis of published studies
L Novotny et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2003)
Serum bilirubin and 10-year mortality risk in a Belgian population
EHM Temme et al.
CANCER CAUSES & CONTROL (2001)
Share Paper
